Characterization of the human patatin-like phospholipase family
Paul A. Wilson(GlaxoSmithKline (United Kingdom)), Daniel Crowther(LFB (France))
Cited by 302
Related Papers
<i>In silico</i>and<i>in vitro</i>evaluation of exonic and intronic off-target effects form a critical element of therapeutic ASO gapmer optimization
|Nucleic Acids Research|2015|109
Strategies for In Vivo Screening and Mitigation of Hepatotoxicity Associated with Antisense Drugs
|Molecular Therapy — Nucleic Acids|2017|62
Pharmacological Characterization of a Novel ENaCα siRNA (GSK2225745) With Potential for the Treatment of Cystic Fibrosis
|Molecular Therapy — Nucleic Acids|2013|37